An entire day worth of news just happened, and there was lots of crap. It’s our job to weed it out and find the jewels. We can’t be a smart-ass about everything out there, but we can give you the rundown of the day’s best stories. Here’s what happened…

• Plexxikon is getting $60M UF from Roche for a novel Raf kinase inhibitor, PLX5568, to treat polycystic kidney disease. Bastards! FierceBiotech

• Generics giant Actavis is up for sale – expecting to grab up to $6B. WSJ Health Blog

• Wynonna Judd ready to get paid by GSK for pushing weight loss drug Alli. We love Perez! Perez Hilton

• The family of Adolf Merckle, the German billionaire who committed suicide this week after his business empire cratered during the global financial crisis, plans to sell off generics maker Ratiopharm to generate cash. Financial Times

• Pfizer to buy Shire? Blah blah blah. BNET Pharma

• Orexigen tanks after-hours on kinda crappy/almost good Contrave data. Damn you traders! The Street

And that’s that…

Image from animaatjes

Related Posts